Acadia Pharmaceuticals price target cut to $36 by RBC
RBC Capital cut its ACADIA Pharmaceuticals price target to $36.00 from $37.00 while maintaining an Outperform rating, per Benzinga via TradingView.
Story updates
02:16:31 PM UTC
SquawkNews
ACADIA Pharmaceuticals Price Target Cut to $36.00/Share From $37.00 by RBC Capital
02:16:47 PM UTC
SquawkNews
ACADIA Pharmaceuticals Is Maintained at Outperform by RBC Capital